Quoted Portfolio Companies
PAION
Unquoted Portfolio Companies
Amura Ltd

Crescendo Biologics

CellCentric Ltd

De Novo Pharmaceuticals

ImmunoBiology Ltd

Medical Device Innovation

Proteom

Purely Proteins
Sold Companies
Paradigm Therapeutics

Cozart plc

Sterix Limited

Cambridge Biotechnology L

Sangamo BioSciences

CeNeS
 
Friday, March 12, 2010

Portfolio Companies

Click here to view larger image.
 
 
 
 
Portfolio balance
Balance is key … Avlar has (and seeks) a spread of investments across a range of technologies and business areas.
 
 
 
 
Therapeutic focus
  • CNS
  • anti infective
  • obesity
  • dermatology
  • oncology
  • therapeutics
  • medical devices
  • prophylactics
  • diagnostics
Stage of development
  • target validation
  • target-to-hit
  • hit-to-lead
  • lead-to-clinical
  • products 
Core Technology
  • proteomics
  • medicinal chemistry
  • computational chemistry
  • silicon chemistry
  • stem cells
Business Model
  • develop and license
  • service company
  • product sales
 

 
 
Privacy Statement | Sitemap | © 2010 Avlar BioVentures Limited

Avlar BioVentures Limited is authorised and regulated by the Financial Services Authority, who require us to state that investments of this type are only suitable for experienced investors familiar with venture capital and biotechnology companies.